Cargando…
Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor
Topoisomerases are interesting targets in cancer chemotherapy. Here, we describe the design and synthesis of a novel copper(II) indenoisoquinoline complex, WN198. The new organometallic compound exhibits a cytotoxic effect on five adenocarcinoma cell lines (MCF-7, MDA-MB-231, HeLa, HT-29, and DU-145...
Autores principales: | Molinaro, Caroline, Wambang, Nathalie, Pellegrini, Sylvain, Henry, Natacha, Lensink, Marc F., Germain, Emmanuelle, Bousquet, Till, de Ruyck, Jérôme, Cailliau, Katia, Pélinski, Lydie, Martoriati, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572568/ https://www.ncbi.nlm.nih.gov/pubmed/37834037 http://dx.doi.org/10.3390/ijms241914590 |
Ejemplares similares
-
A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
por: Molinaro, Caroline, et al.
Publicado: (2022) -
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020) -
Effects of Ferrocenyl 4-(Imino)-1,4-Dihydro-quinolines on Xenopus laevis Prophase I - Arrested Oocytes: Survival and Hormonal-Induced M-Phase Entry
por: Marchand, Guillaume, et al.
Publicado: (2020) -
Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
por: Molinaro, Caroline, et al.
Publicado: (2021) -
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
por: Pommier, Yves, et al.
Publicado: (2018)